584 related articles for article (PubMed ID: 24340506)
1. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
2. [EUROGIN 2010: roadmap on cervical cancer prevention].
Monsonego J
Gynecol Obstet Fertil; 2011; 39(7-8):462-7. PubMed ID: 21764621
[No Abstract] [Full Text] [Related]
3. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
Crum CP; Abbott DW; Quade BJ
J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
[TBL] [Abstract][Full Text] [Related]
4. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.
Bornstein J; Fisher WA; Ginsberg GM; Shavit O; Schejter E; Diaz M; Bosch FX
Vaccine; 2013 Nov; 31 Suppl 8():I58-60. PubMed ID: 24229721
[No Abstract] [Full Text] [Related]
5. HPV testing could cut cervical cancers by a third, finds study.
Kmietowicz Z
BMJ; 2013 Jun; 346():f3888. PubMed ID: 23771041
[No Abstract] [Full Text] [Related]
6. HPV-vaccine and screening programs: the new era of global prevention.
Mariani L
J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438
[No Abstract] [Full Text] [Related]
7. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
8. [HPV vaccination and testing can improve cervix cancer screening].
Bistoletti P; Andersson S; Johansson BC
Lakartidningen; 2008 Jan 9-15; 105(1-2):56-7. PubMed ID: 18293750
[No Abstract] [Full Text] [Related]
9. [The advantage of a specialized HPV clinic within the department of proctology].
Skala K; Zufferey G; Robert-Yap J; Morel P; Roche B
Rev Med Suisse; 2011 Jun; 7(300):1348-50, 1352-3. PubMed ID: 21815534
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
Chelimo C; Wouldes TA; Cameron LD; Elwood JM
J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
El-Zein M; Richardson L; Franco EL
J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958
[TBL] [Abstract][Full Text] [Related]
12. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
13. [HPV testing and cervical cancer screening. Evidences, resistances and current practices].
Monsonego J
Gynecol Obstet Fertil; 2012 May; 40(5):269-72. PubMed ID: 22521159
[No Abstract] [Full Text] [Related]
14. [Summary of the practice guideline 'Prevention and early diagnosis of cervical cancer' of the Dutch College of General Practitioners].
Janssen PG; Boomsma LJ; Buis PA; Collette C; Boukes FS; Goudswaard AN
Ned Tijdschr Geneeskd; 2009; 153():A517. PubMed ID: 20051149
[TBL] [Abstract][Full Text] [Related]
15. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
16. [Cervical cancer screening: restoration or reconstruction?].
Riethmuller D
Gynecol Obstet Fertil; 2009; 37(7-8):671-9. PubMed ID: 19577501
[No Abstract] [Full Text] [Related]
17. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania].
Feticu L; Bocşan IS; Bondor Cl; Boboş C
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):567-74. PubMed ID: 23077955
[TBL] [Abstract][Full Text] [Related]
19. [Test for human papillomavirus: no added value by inclusion in improved population screening for cervical cancer at this point].
Hanselaar AG
Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1668-71. PubMed ID: 10981233
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
